Since most of the work is in setting up the necessary tools and pipelines to evaluate, I will lump the actual act of evaluating on specific data into this single ticket. We need to:
CRSP specificity: apply Takuto's mutect2-replicate-validation.wdl on the CRSP NA12878 replicates.
CRSP sensitivity: apply the (currently in-progress) hapmap sensitivity pipeline to CRSP data.
cfDNA: run cfDNA samples and matched solid tumor samples (which we already have from Viktor) and run the concordance tool.
FFPE: run FFPE and matched non-FFPE samples and run the concordance tool.
tumor-only: run some TCGA samples with and without their matched normal and run the concordance tool.
Update: CRSP sensitivity and specificity have been run several times, cfDNA is currently running for the first time. FFPE and tumor-only will use the same wdl as cfDNA, so we'll run those once cfDNA finishes.
@davidbenjamin commented on Wed Feb 15 2017
Since most of the work is in setting up the necessary tools and pipelines to evaluate, I will lump the actual act of evaluating on specific data into this single ticket. We need to:
mutect2-replicate-validation.wdl
on the CRSP NA12878 replicates.@davidbenjamin commented on Wed Mar 15 2017
Update: CRSP sensitivity and specificity have been run several times, cfDNA is currently running for the first time. FFPE and tumor-only will use the same wdl as cfDNA, so we'll run those once cfDNA finishes.
@davidbenjamin commented on Mon Mar 20 2017
Update: everything done except FFPE and tumor-only. FFPE will use the same wdl as cfDNA.